Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III trial of 0.02% and 0.04% atropine sulfate eye drops for slowing myopia progression in children
CTR20212468Phase 3Completed
- Sponsor
- Xingqi Eye Medicine
- Start
- Dec 2021
- Modality
- Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of atropine in myopia, sponsored by Xingqi Eye Medicine. Started Dec 2021; status: completed.
02
Drugs
atropine
03
Conditions
myopia
Beyond the preview
Go deeper on CTR20212468.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20212468.